EPISODE · Oct 16, 2025 · 17 MIN
From Diagnosis to Drug Development
from Moving Medicine Forward · host CTI Clinical Trials
Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-centered research, and the role of collaboration in advancing drug development, highlighting resilience, innovation, and the impact of clinical trials.
NOW PLAYING
From Diagnosis to Drug Development
No transcript for this episode yet
Similar Episodes
Dec 18, 2025 ·14m
Jul 26, 2025 ·9m
Feb 18, 2025 ·12m
Feb 10, 2025 ·2m
Feb 7, 2025 ·3m
Dec 7, 2024 ·64m